Hi group;

our OB colleagues use Methergine (ergonovine) for treatment or prophylaxis of postpartum hemorrhage. The medication label from the manufacturer recommends to hold breast feeding up to 12 hours after last dose due to unpublished reported side effects in the babies

i did a literature search and found only one article published in Pubmed that covers that topic: https://pubmed.ncbi.nlm.nih.gov/27846760/

min this prospective study they found no side effects in breastfed babies 

Are there any other reference on this topic that you can share?

is this something that affects your newborn nursery practice in your hospital?

Thanks for any input 

I found this more extensive writeup about methergine in LactMed, but otherwise nothing more substantial info

Interesting how unpublished case reports (to the manufacturer) can have such impact.

https://www.ncbi.nlm.nih.gov/books/NBK501342/

Hi Johan;

thanks for your insight. That’s the reality of my hospital. The anti lactation has taken this unpublished recommendation to prevent mother to lactate their infants